Head Stabilization in Whole Brain RT

Launched by ABRAMSON CANCER CENTER AT PENN MEDICINE · Jan 14, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on improving the way patients' heads are stabilized during whole brain radiation therapy, which is a treatment for brain cancer. Researchers are developing a new system that helps keep the head still, making the treatment more effective and comfortable. This study is observational, meaning that the researchers will closely watch how the new system works without changing any treatment plans.

To be eligible for this study, participants must be 18 years or older and scheduled to receive whole brain radiation therapy. They also need to agree to take part by signing a consent form. The trial is not yet open for recruitment, but once it is, participants can expect to use the new motion control system during their treatment sessions, with the goal of enhancing their overall experience and treatment outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 and older undergoing whole brain radiation therapy
• • Participants must sign the informed consent form
• Exclusion Criteria:
• • All patients not meeting the above inclusion criteria will not be considered for this study.